CVspectrum.org
GO TO: Register Now! SIGN IN



SEARCH


Advanced Search >>
BROWSE





Continuing Education

Send This Page By E-mail
Print this page

Goals of Lipid-Lowering Therapy


Released: 11-15-04
Expires: 11-15-06


Jointly sponsored by:

   and 

The FCG Institute for Continuing Education and IntraMed Scientific Solutions gratefully acknowledge an educational grant from AstraZeneca Pharmaceuticals LP in support of this continuing medical education activity.
 

 


Overview
Guidelines to govern a clinician’s response to cardiovascular disease (CVD) and coronary artery disease (CAD) risk in his or her patient population have been evolving steadily since the Framingham Heart Study began to establish definitively 1) that there are specific risk factors associated with increased incidence of CVD and CAD and 2) that many of these risk factors can be modified. In this presentation, we review recent recommended modifications based on clinical trials, as well as specific risk factors and categories contributing to the assessment of global risk for CAD.

Goal
To provide health-care professionals with an evidence-based overview of risk assessment and treatment of CAD in the US.

Target Audience
Goals of Lipid-Lowering Therapy is intended for physicians, pharmacists, nurses, and nurse practitioners with an interest in dyslipidemia.

Learning Objectives
Following completion of this activity, participants should be able to:

    • Evaluate revised guidelines for cholesterol management and adjustments in therapeutic lipid goals based on information from recent clinical trials
    • Define NCEP ATP III guidelines for estimating global risk for CAD
    • Identify NCEP ATP III guidelines for diagnosis of metabolic syndrome and present defining levels for individual metabolic syndrome risk components
    • Utilize CVD risk stratification and intervention thresholds developed for women
    • Apply new CAD risk category classifications based on recent clinical trial implications and provide inclusion criteria for each

Accreditation and Credit Designation Statements

CME

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The FCG Institute of Continuing Education and IntraMed Scientific Solutions. The FCG Institute for Continuing Education is accredited by the ACCME to provide continuing medical education for physicians.

The FCG Institute for Continuing Education designates this educational activity for a maximum of 1.25 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA category 1 credit.

CPE
The FCG Institute for Continuing Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned the Universal Program Number 086-999-04-023-H01and has been approved for 1.4 contact hours (0.14 CEUs).

CNE
The FCG Institute for Continuing Education is an approved provider of continuing nursing education by Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This activity is certified for 1.4 contact hours.

CNPE
This program has been approved for 1.4 contact hours of continuing education by the American Academy of Nurse Practitioners. Program ID 0411464.

How to Receive CE Credit
To receive credit for this CE activity, you must review the entire slide kit, complete an evaluation and credit request form, and score 70% or higher on the posttest. Forms must be submitted by 11-15-06 to: The FCG Institute for Continuing Education-2326-4, 1140 Welsh Road, Suite 210, North Wales, PA 19454; or Fax to: 215-412-9686. A certificate will be mailed to you in 4-6 weeks of our receipt of the completed 2-page form. There is no fee associated with this activity and it should take approximately 1.25 hours to complete.

To access the presentation, posttest, and CE Credit form, please follow the links at the bottom of this page to view and/or download.

Release and Expiration
This activity was released on 11/15/04 and will expire on 11/15/06.

Unlabeled or Investigational Use Statement
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the US Food and Drug Administration (FDA). The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off label or investigational uses (any use not approved by the FDA) of products or devices.

The FCG Institute for Continuing Education, the faculty, and AstraZeneca Pharmaceuticals LP do not endorse the use of any product outside of the FDA-labeled indications. Healthcare professionals should not utilize the procedures, products, or diagnostic techniques discussed during this activity without evaluation of their patients for contraindications or dangers of use.

Disclosure Statement
It is the policy of the FCG Institute for Continuing Education to ensure independence, balance, objectivity, and scientific rigor and integrity in all its CE activities. Faculty must disclose to the participants any significant relationships with commercial companies whose products or devices may be mentioned in faculty presentations or with the commercial supporter of this activity. Disclosure information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Faculty
Dr. Jeffrey Shanes served as the course director for this slide kit.

Faculty Disclosure Statement
Dr. Shanes has disclosed that he has received grants/research support and honoraria from AstraZeneca Pharmaceuticals LP.

Click here to verify that you have read and accept the CE Information and Terms above

Presentation

Click here to view presentation

Click here to download presentation

Posttest and CE Credit Form

Click here to download

Please note: you may have to select the refresh button on your Web browser to view the Posttest and the CE Credit Form.

CE Activity Viewing Requirements

You must be a registered cvspectrum.org user to review and/or receive credit for this CE Activity. Registered users, login now by clicking here. If you are not already a registered member of the cvspectrum.org community and would like to access this CE Activity, Register Now

MORE CONTINUING EDUCATION

You can access more online and offline continuing education activities through these areas:

CVspectrum.org

Annenberg Center for Health Sciences      Supported by educational grants from Abbott Laboratories, Daiichi-Sankyo, Inc., and Eli Lilly and Company.
Supported by an educational grant from Molecular Insight Pharmaceuticals, Inc.
Molecular Insights
Independent Medical Education © Copyright 2010 CVspectrum.org.      About CVspectrum | Terms of Use | Privacy Policy | Site Map | Contact Us